spacer
The Healthcare Sales & Marketing Network celebrates 25 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  lung transplant 

 HSMN NewsFeed - 21 Jul 2021
FDA Grants Breakthrough Designation to Synapse Biomedical's TransAeris(R) System
Devices FDA
 HSMN NewsFeed - 8 Jan 2020
Altavant Sciences Acquires Onspira Therapeutics, Adding a Potentially Life-Saving Treatment for Post-Lung Transplant Patients to the Altavant Pipeline
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 6 Aug 2019
BioVentrix Announces Key Additions to Leadership Team
Devices Cardiology Personnel
 HSMN NewsFeed - 20 Jun 2019
CollPlant Announces Corporate Name Change to CollPlant Biotechnologies to Better Reflect Its Business
Regenerative Medicine Wound Care
 HSMN NewsFeed - 26 Mar 2019
Breath Therapeutics Announces Initiation of Global Phase 3 Trials for the Treatment of Bronchiolitis Obliterans Syndrome
Biopharmaceuticals
 HSMN NewsFeed - 12 Nov 2018
CollPlant Announces Closing of Global Licensing and Commercialization Agreement With United Therapeutics for 3D Bioprinting of Solid-Organ Scaffolds for Human Transplants
Devices Regenerative Medicine Licensing
 HSMN NewsFeed - 8 May 2018
TFF Pharmaceuticals Announces Appointment of Glenn Mattes as New Chief Executive Officer
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 12 Apr 2018
TransMedics, Inc. Receives FDA Pre-Market Approval (PMA) for its OCS(TM) Lung System for Near-Physiologic Preservation and Assessment of Lungs for Transplantation
Devices Surgery FDA
 HSMN NewsFeed - 3 Apr 2018
Biopharm Startup TFF Pharmaceuticals Raises $14M for Breakthrough Dry Powder Inhalation Platform
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 10 May 2017
Savara Announces Expedited U.S. Molgradex Development Strategy
Biopharmaceuticals FDA
 HSMN NewsFeed - 16 Mar 2017
Biostage Promotes Saverio La Francesca, M.D. to President
Devices Regenerative Medicine Personnel
 HSMN NewsFeed - 8 Feb 2017
Kamada Announces Appointment of Biopharmaceutical Industry Veteran, Gwen Melincoff, to its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 9 Nov 2016
Paragonix Technologies, Inc., and Pacific West Medical Sales Announce Distribution Agreement of Paragonix SherpaPak(TM) Transport Systems
Devices Surgery Distribution
 HSMN NewsFeed - 6 Oct 2016
Kamada Announces Extension of GLASSIA(R) Supply and Distribution Agreement with Shire with Minimum $237 Million of Revenue for the Years 2017 to 2020
Biopharmaceuticals Distribution Licensing
 HSMN NewsFeed - 1 Sep 2016
Kamada and Kedrion Seek FDA Approval of Human Rabies Immunoglobulin as a Post-Exposure Treatment
Biopharmaceuticals FDA
 HSMN NewsFeed - 26 May 2016
TransMedics, Inc. Announces Closing of $51.2 Million Growth Financing to Transform Organ Transplant Therapy
Devices Venture Capital
 HSMN NewsFeed - 11 Mar 2016
HeartStitch, Inc. Appoints Renowned Cardiac Surgeon to Its Clinical Advisory Board
Devices Cardiology Surgery Personnel
 HSMN NewsFeed - 25 Feb 2014
InterMune Reports Phase 3 ASCEND Trial Results of Pirfenidone in Idiopathic Pulmonary Fibrosis (IPF)
Biopharmaceuticals
 HSMN NewsFeed - 12 Dec 2013
Advanced Cell Technology Appoints Eddy Anglade M.D. Executive Vice President of Clinical Development
Regenerative Medicine Personnel
 HSMN NewsFeed - 12 Nov 2013
1,200th Worldwide Implant of the SynCardia Total Artificial Heart Occurs in Indiana
Devices Cardiology
 HSMN NewsFeed - 8 Nov 2013
Pfizer Announces Top-Line Results Of Phase 3B/4 Study Of RAPAMUNE(R) (sirolimus) In Renal Transplant Recipients
Biopharmaceuticals
 HSMN NewsFeed - 23 Sep 2013
Bayer receives approval for Adempas(R) as first drug to treat rare heart and lung disease
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 9 May 2013
Sunshine Heart, Inc. Announces First Patient Implanted in C-Pulse System European Post-Market Study
Devices Cardiology
 HSMN NewsFeed - 26 Feb 2013
Cytori Appoints Dr. Steven Kesten as Executive Vice President and Chief Medical Officer
Regenerative Medicine Personnel
 HSMN NewsFeed - 12 Feb 2013
Paragonix Technologies, Inc., Announces Clearance of a 510(k) Pre-Marketing Notification Application with the US Food and Drug Administration for the Paragonix Sherpa(TM) Cardiac Transport System
Devices Cardiology FDA
 HSMN NewsFeed - 31 Jan 2013
Pfizer Wins RAPAMUNE(R) Patent Case in Delaware District Court
Biopharmaceuticals Litigation
 HSMN NewsFeed - 27 Nov 2012
TransMedics, Inc. Secures $36 Million Round of Financing Led by Abrams Capital Management
Devices Venture Capital
 HSMN NewsFeed - 8 Nov 2012
Genoa Pharmaceuticals announces $1.2M Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 26 Oct 2012
NICE Approves Pharmaxis' Bronchitol(R) As An Important New Treatment Option For Cystic Fibrosis Patients
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 5 Sep 2012
CircuLite(R) Receives CE Marking Approval for SYNERGY(R) Circulatory Support System
Devices Cardiology Regulatory
 HSMN NewsFeed - 25 Jun 2012
Paragonix Technologies Inc., Announces Appointment of Leonard A. R. Golding, MB, BS, FRACS, FRCS(C), FACC as Chief Medical Officer
Devices Cardiology Personnel
 HSMN NewsFeed - 31 Aug 2011
NexBio's DAS181 (Fludase(R)*) Improves Symptoms in Four Severely Immunocompromised Patients With Life-Threatening Parainfluenza Pneumonitis
Biopharmaceuticals
 HSMN NewsFeed - 27 Apr 2011
Deep Breeze Introduces Breeze@home(TM) -- A New Telemonitoring Device to Improve COPD Assessment
Devices Monitoring
 HSMN NewsFeed - 1 Nov 2010
Steven Kesten, M.D., Leader in Pulmonary Medicine, Joins Uptake Medical as Vice President and Chief Medical Officer
Devices Personnel
 HSMN NewsFeed - 27 Sep 2010
Deep Breeze Launches Unique, Non-Invasive, Radiation-Free Emergency Department Pulmonary Imaging System in the U.S.
Devices
 HSMN NewsFeed - 20 Sep 2010
Aeris Therapeutics Announces CE Mark Approval for the AeriSeal(R) Emphysematous Lung Sealant System
Devices Regulatory
 HSMN NewsFeed - 8 Sep 2010
XDx Appoints New Vice President of Corporate Development and Legal Affairs
Diagnostics Personnel
 HSMN NewsFeed - 13 Aug 2010
Inspire Names Dr. Charles Johnson as Executive Vice President of Research and Development and Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 25 Jun 2010
Olympus to Acquire Spiration, Inc., a U.S. Pulmonary Device Company, as a Consolidated Subsidiary
Devices Mergers & Acquisitions
 HSMN NewsFeed - 19 May 2010
Spiration Announces Positive Results of European Study Evaluating Safety and Effectiveness of Bronchial Valve Treatment for Severe Emphysema
Devices
 HSMN NewsFeed - 11 Jan 2010
Alnylam Provides Key Goals and Guidance for Next 12 to 18 Months
Biopharmaceuticals
 HSMN NewsFeed - 14 Dec 2009
Cubist Pharmaceuticals to Acquire Calixa Therapeutics
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 11 Dec 2009
Trial Date Set for CUBICIN(R) Patent Litigation
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 28 Sep 2009
CardiAQ Valve Technologies (CVT) Discloses Successful Results of Acute In Vivo Study of Its Novel Transcatheter Mitral Valve Implantation (TMVI) System
Devices Interventional Cardiology
 HSMN NewsFeed - 31 Aug 2009
FDA Approves Valcyte(R) (valganciclovir hydrochloride) to Prevent Cytomegalovirus (CMV) Disease in Pediatric Patients Who Receive Heart or Kidney Transplants
Biopharmaceuticals FDA
 HSMN NewsFeed - 3 Aug 2009
CMS Approves New Technology Add-On Payment for Spiration(R) IBV Valve System
Devices Reimbursement
 HSMN NewsFeed - 26 May 2009
FDA Approves ADCIRCA(TM) (Tadalafil) Tablets for the Treatment of Pulmonary Arterial Hypertension
Biopharmaceuticals FDA
 HSMN NewsFeed - 5 May 2009
Titan Medical Inc. Announces the Appointment of Dr. W. Douglas Boyd as Principal Investigator
Devices Cardiology
 HSMN NewsFeed - 24 Apr 2009
An Independent Study Reports on the Utility of ImmuKnow(R), the Cylex(TM) Immune Cell Function Assay, for Monitoring Heart Transplant Recipients
Diagnostics Cardiology
 HSMN NewsFeed - 17 Mar 2009
David Feldman, M.D. Appointed Co-Principal Investigator of DuraHeart(TM) Left Ventricular Assist System U.S. Clinical Trial
Devices Cardiology Personnel
 HSMN NewsFeed - 20 Feb 2009
Nebraska Heart Institute First in the Nation to Implant Acorn(TM) Heart Failure Device Minimally Invasively
Devices Cardiology
 HSMN NewsFeed - 13 Feb 2009
IMPACT Study Demonstrates That Longer Prophylactic Therapy With Valcyte(R) (Valganciclovir Hydrochloride Tablets) Increases Protection Against CMV - the Most Serious Viral Infection Affecting Transplant Patients
Biopharmaceuticals
 HSMN NewsFeed - 18 Dec 2008
First Lung Lesion and First Lymph Node Metastasis Treated With AngioDynamics’ IRE Technology at Australia’s The Alfred Hospital
Devices Oncology
 HSMN NewsFeed - 4 Dec 2008
Broncus Technologies Secures $38 Million in Funding Round Led by Ares Life Sciences
Devices Venture Capital
 HSMN NewsFeed - 28 Oct 2008
Gilead Announces Two-Year Clinical Data for Letairis(R) (ambrisentan) for the Treatment of Pulmonary Arterial Hypertension (WHO Group 1)
Biopharmaceuticals
 HSMN NewsFeed - 24 Oct 2008
Spiration, Inc. Receives First FDA Approval for Bronchial Valve
Devices FDA
 HSMN NewsFeed - 8 Oct 2008
Spiration, Inc. Announces European Launch of Minimally Invasive Pulmonary Device
Devices
 HSMN NewsFeed - 30 Sep 2008
APT Pharmaceuticals Secures $32 Million in Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 3 Sep 2008
MAP Pharmaceuticals Appoints Alan H. Cohen, M.D., as Vice President, Clinical Development and Medical Affairs, Pulmonary
Biopharmaceuticals Personnel
 HSMN NewsFeed - 29 May 2008
Data from Pivotal Phase III Studies of Gilead's Letairis(R) (ambrisentan) for Pulmonary Arterial Hypertension (WHO Group 1) in Patients with WHO Functional Class II or III Symptoms Published in Circulation
Biopharmaceuticals
 HSMN NewsFeed - 19 May 2008
Olympus Medical Systems Corp. and Spiration, Inc. Sign Agreement to Market and Distribute Minimally Invasive Pulmonary Device in 43 European Countries
Devices Distribution
 HSMN NewsFeed - 9 Apr 2008
World's First 4-lb Discharge Driver For Powering CardioWest Artificial Heart Unveiled at ISHLT in Boston
Devices Cardiology
 HSMN NewsFeed - 7 Jan 2008
Abiomed Announces AB5000(R) Portable Circulatory Support Driver
Devices Cardiology
 HSMN NewsFeed - 3 Dec 2007
APT Pharmaceuticals Adds Paul Sekhri to Board of Directors
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 19 Nov 2007
APT Pharmaceuticals Expands Management Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 22 Oct 2007
Deep Breeze Ltd. Launches Unique Non-Invasive, Radiation-Free Pulmonary Imaging System in the U.S.
Devices
 HSMN NewsFeed - 4 Oct 2007
APT Pharmaceuticals Closes New $22 Million Funding Round
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 26 Sep 2007
Spiration, Inc. Announces First Patient Enrollment in U.S. Pivotal Trial of Minimally Invasive Treatment for Severe Emphysema
Devices
 HSMN NewsFeed - 19 Sep 2007
Spiration Inc. Announces Positive Results from Pilot Study of Treatment for Patients with Severe Emphysema at European Respiratory Society's Annual Congress
Devices
 HSMN NewsFeed - 10 Aug 2007
MAP Pharmaceuticals Promotes Stephen B. Shrewsbury to Position of Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 9 Aug 2007
FDA Clears Unique Non-Invasive, Radiation-Free Pulmonary Imaging System
Devices FDA
 HSMN NewsFeed - 15 Jun 2007
U.S. Food and Drug Administration Approves Gilead's Letairis(TM) (ambrisentan) 5 mg and 10 mg Tablets for the Once-Daily Treatment of Pulmonary Arterial Hypertension (WHO Group 1) in Patients with WHO Functional Class II or III Symptoms
Biopharmaceuticals FDA
 HSMN NewsFeed - 5 Jun 2007
APT Acquires Exclusive Worldwide Rights to Develop and Commercialize Inhalable Cyclosporine to Prevent Lung Transplant Rejection
Biopharmaceuticals Drug Delivery Licensing
 HSMN NewsFeed - 31 May 2007
Abiomed Appoints Eric A. Rose, M.D., a Leader in Circulatory Care, to Its Board of Directors
Devices Cardiology
 HSMN NewsFeed - 27 Apr 2007
VentrAssist(TM) LVAD First 100 Patients - Clinical Data Presented at International Society of Heart and Lung Transplantation meeting
Devices Cardiology
 HSMN NewsFeed - 26 Apr 2007
TransMedics, Inc. Announces Successful Results for First Ever Beating Heart Transplant Study Using the Organ Care System
Devices
 HSMN NewsFeed - 19 Apr 2007
FDA Grants IDE Approval to TransMedics for the Pilot Phase of the PROCEED Clinical Trial for Its Organ Care System(TM) - the First System to Support Beating Heart Transplant
Devices FDA
 HSMN NewsFeed - 7 Mar 2007
CircuLite(TM) Closes $20M Series B Private Placement Funding
Devices Cardiology Venture Capital
 HSMN NewsFeed - 2 Feb 2007
FDA Approves New Dosing Recommendations for RAPAMUNE in High Immunologic Risk Renal Transplant Patients
Biopharmaceuticals FDA
 HSMN NewsFeed - 16 Nov 2006
Bioheart, Inc. Expands Clinical Trials of Adult Myogenic Stem Cell Treatment for Heart Attack and Advanced Heart Failure Patients
Regenerative Medicine Cardiology
 HSMN NewsFeed - 31 Oct 2006
Gene Expression Test From XDx Now Indicated for Earlier Use and Prediction of Acute Cellular Rejection
Diagnostics Cardiology Reimbursement
 HSMN NewsFeed - 16 Aug 2006
XDx Announces Appointment of Dr. James Yee as Chief Medical Officer
Diagnostics Personnel
 HSMN NewsFeed - 27 Jun 2006
FDA Approves Abiomed's IDE for IMPELLA 5.0 Minimally Invasive Cardiac Support Systems
Devices Cardiology FDA
 HSMN NewsFeed - 2 Jun 2006
Encysive Pharmaceuticals' Thelin(TM) (sitaxentan sodium) Receives Positive Opinion From European Authorities
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 10 Apr 2006
Study Reports WorldHeart Novacor LVAS Patients Enjoy Higher Quality of Life
Devices Cardiology
 HSMN NewsFeed - 5 Apr 2006
WorldHeart Expands RELIANT Trial Clinical Executive Committee
Devices Personnel
 HSMN NewsFeed - 3 Apr 2006
Nabi Biopharmaceuticals Acquires Exclusive North American Commercialization Rights to Phase III Antibody Product for Prevention and Treatment of Rejection Following Organ Transplantation
Biopharmaceuticals
 HSMN NewsFeed - 10 Feb 2006
Norman Shumway, Heart Transplantation Pioneer, Dies at 83
Cardiology Surgery Personnel
 HSMN NewsFeed - 2 Feb 2006
Dr. Thomas Stegmann, Cardiovascular Surgeon and Pioneer in Field of Angiogenesis, Commits to CVBT on a Full-Time Basis
Biopharmaceuticals Cardiology Personnel
 HSMN NewsFeed - 10 Jan 2006
MCRI Granted FDA Approval to Conduct Reduced Anticoagulation Clinical Trial of On-X Prosthetic Heart Valve
Devices Cardiology FDA
Return to NewsFeed  

 Additional items found! 47

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 47 additional stories matching:
lung transplant
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.